JP2012508865A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2012508865A5 JP2012508865A5 JP2011535211A JP2011535211A JP2012508865A5 JP 2012508865 A5 JP2012508865 A5 JP 2012508865A5 JP 2011535211 A JP2011535211 A JP 2011535211A JP 2011535211 A JP2011535211 A JP 2011535211A JP 2012508865 A5 JP2012508865 A5 JP 2012508865A5
- Authority
- JP
- Japan
- Prior art keywords
- antigens
- listed
- pattern
- group
- reactivity
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US11364508P | 2008-11-12 | 2008-11-12 | |
| US61/113,645 | 2008-11-12 | ||
| PCT/IL2009/001066 WO2010055510A2 (en) | 2008-11-12 | 2009-11-12 | Diagnosis of multiple sclerosis |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2012508865A JP2012508865A (ja) | 2012-04-12 |
| JP2012508865A5 true JP2012508865A5 (enExample) | 2012-12-27 |
Family
ID=42170484
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2011535211A Pending JP2012508865A (ja) | 2008-11-12 | 2009-11-12 | 多発性硬化症の診断 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US9267945B2 (enExample) |
| EP (1) | EP2353004B1 (enExample) |
| JP (1) | JP2012508865A (enExample) |
| CN (1) | CN102388307B (enExample) |
| AU (1) | AU2009315230A1 (enExample) |
| CA (1) | CA2743590A1 (enExample) |
| WO (1) | WO2010055510A2 (enExample) |
Families Citing this family (27)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20140105980A1 (en) | 2012-10-11 | 2014-04-17 | Uti Limited Partnership | Methods and compositions for treating multiple sclerosis and related disorders |
| EP2629797B1 (en) | 2010-10-19 | 2018-05-23 | The Regents of the University of Colorado, A Body Corporate | Peptides for modulating t-cell activity and uses thereof |
| US20190263888A1 (en) | 2010-10-19 | 2019-08-29 | Op-T Llc | Therapeutic peptides and methods for treating autoimmune related disease |
| US9511151B2 (en) | 2010-11-12 | 2016-12-06 | Uti Limited Partnership | Compositions and methods for the prevention and treatment of cancer |
| US10988516B2 (en) | 2012-03-26 | 2021-04-27 | Uti Limited Partnership | Methods and compositions for treating inflammation |
| US8652999B1 (en) | 2012-07-24 | 2014-02-18 | Dow Agrosciences, Llc. | Herbicidal compositions comprising 4-amino-3-chloro-5-fluoro-6-(4-chloro-2-fluoro-3-methoxyphenyl)pyridine-2-carboxylic acid or a derivative thereof and a sulfonylaminocarbonyltriazolinone |
| US9603948B2 (en) | 2012-10-11 | 2017-03-28 | Uti Limited Partnership | Methods and compositions for treating multiple sclerosis and related disorders |
| GB201300684D0 (en) | 2013-01-15 | 2013-02-27 | Apitope Int Nv | Peptide |
| SG10201803780UA (en) | 2013-11-04 | 2018-06-28 | Uti Lp | Methods and compositions for sustained immunotherapy |
| WO2015089443A2 (en) * | 2013-12-12 | 2015-06-18 | The Brigham And Women's Hospital, Inc. | Treating neurodegenerative disease |
| US20160320384A1 (en) | 2013-12-31 | 2016-11-03 | Yeda Research And Development Co. Ltd. | Methods for assaying immunological competence |
| EP3090064B1 (en) | 2013-12-31 | 2019-11-13 | Yeda Research and Development Co. Ltd. | Diagnosis of systemic lupus erythematosus using oligonucleotides antigens |
| US20170108514A1 (en) * | 2014-03-23 | 2017-04-20 | The Regents Of The University Of Colorado, A Body Corporate | Diagnosis of multiple sclerosis in human and animal subjects |
| EP2927687A1 (en) * | 2014-03-31 | 2015-10-07 | Ecole Polytechnique Federale de Lausanne (EPFL) | Agents useful in diagnostic and therapy of beta-amyloid aggregation related disorders and screening methods |
| WO2015172008A1 (en) * | 2014-05-09 | 2015-11-12 | Multiple Sclerosis Research Center Of New York | Transglutaminadase 6 as a biomarker for multiple sclerosis |
| US10495646B2 (en) | 2015-01-30 | 2019-12-03 | The Regents Of The University Of California | N-acetyl glucosamine as a biomarker of MS disease course |
| US11047855B2 (en) | 2015-03-01 | 2021-06-29 | Immunarray Ltd. | Diagnosis of systemic lupus erythematosus using protein, peptide and oligonucleotide antigens |
| ES3055030T3 (en) | 2015-05-06 | 2026-02-09 | Uti Lp | Nanoparticle compositions for sustained therapy |
| CN107043413A (zh) * | 2016-02-05 | 2017-08-15 | 华中农业大学 | 一种肺结核相关的尿液生物标志蛋白及其应用 |
| WO2018048884A1 (en) * | 2016-09-09 | 2018-03-15 | Mayo Foundation For Medical Education And Research | Methods and materials for identifying and treating autoimmune gfap astrocytopathy |
| US20180127481A1 (en) | 2016-11-09 | 2018-05-10 | Uti Limited Partnership | RECOMBINANT pMHC CLASS II MOLECULES |
| SG11201909290TA (en) | 2017-04-07 | 2019-11-28 | Uti Lp | Assay to measure the potency of receptor-ligand interactions in nanomedicines |
| EP3716949A4 (en) | 2017-11-29 | 2022-05-18 | UTI Limited Partnership | METHODS OF TREATMENT OF AUTOIMMUNE DISEASES |
| US11793854B2 (en) | 2019-03-21 | 2023-10-24 | Op-T Llc | Methods for reducing symptoms of multiple sclerosis using a six-amino acid long peptide that inhibits CD40-CD150 interaction |
| US12048734B2 (en) | 2020-04-17 | 2024-07-30 | Op-T Llc | Bioactive peptides and methods of use thereof |
| CN114689865A (zh) * | 2020-12-30 | 2022-07-01 | 广州市微米生物科技有限公司 | 视神经脊髓炎抗体检测试剂 |
| CN113336862B (zh) * | 2021-07-05 | 2022-03-01 | 广东省科学院动物研究所 | 一种抗多发性硬化的重组蛋白及其制备方法和用途 |
Family Cites Families (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL137460A0 (en) | 2000-07-24 | 2001-07-24 | Yeda Res & Dev | Identifying antigen clusters for monitoring a global state of an immune system |
| JP4394350B2 (ja) | 2001-01-09 | 2010-01-06 | ベイラー リサーチ インスティテュート | 対象における自己免疫疾患の治療法及びｉｎｖｉｔｒｏ診断アッセイ |
| EP1386155A4 (en) | 2001-04-10 | 2006-05-10 | Univ Leland Stanford Junior | THERAPEUTIC AND DIAGNOSTIC USE OF ANTIBODY SPECIFICITY PROFILES |
| US20030092089A1 (en) | 2001-11-14 | 2003-05-15 | Moscarello Mario Anthony | Method for diagnosing multiple sclerosis and an assay therefore |
| IL148401A0 (en) * | 2002-02-26 | 2002-09-12 | Hadasit Med Res Service | Hsp70-derived peptides and uses thereof in the diagnosis and treatment of autoimmune diseases |
| WO2004034031A2 (en) | 2002-10-11 | 2004-04-22 | The Regents Of The University Of California | A method for diagnosis and prognosis of multiple sclerosis |
| US20050260770A1 (en) | 2004-04-01 | 2005-11-24 | Cohen Irun R | Antigen array and diagnostic uses thereof |
| EA200700263A1 (ru) | 2004-07-01 | 2007-06-29 | Кебенхавнс Университет | Способ лечения и профилактики рассеянного склероза путём лечения лептоспирозной инфекции |
| US20080194711A1 (en) * | 2005-01-19 | 2008-08-14 | Frauke Zipp-Nitsch | Cx3Cr1 As A Marker Which Correlates With Both Disease And Disease Activity In Multiple Sclerosis Patients |
| US7572592B2 (en) * | 2005-01-31 | 2009-08-11 | Glycominds Ltd | Method for diagnosing multiple sclerosis |
| CN101218254A (zh) | 2005-02-14 | 2008-07-09 | 惠氏公司 | 白介素-17f抗体及其它il-17f信号传递拮抗剂和它们的用途 |
| WO2006116155A2 (en) * | 2005-04-21 | 2006-11-02 | The Regents Of The University Of California | A method for diagnosis and prognosis of multiple sclerosis subtypes |
| WO2007014001A2 (en) * | 2005-07-21 | 2007-02-01 | The Board Of Trustees Of The Leland Stanford Junior University | Multiplex determination of lipid specific binding moieties |
| WO2007056332A2 (en) * | 2005-11-07 | 2007-05-18 | Vanderbilt University | Molecular diagnosis of autoimmune diseases |
| SG171691A1 (en) | 2006-05-26 | 2011-06-29 | Phenomenome Discoveries Inc | Biomarkers for diagnosing multiple sclerosis, and methods thereof |
| CA2683865A1 (en) * | 2007-04-12 | 2008-10-23 | Apitope International Nv | Biomarkers for multiple sclerosis |
-
2009
- 2009-11-12 EP EP09825840.3A patent/EP2353004B1/en not_active Not-in-force
- 2009-11-12 US US13/128,862 patent/US9267945B2/en not_active Expired - Fee Related
- 2009-11-12 WO PCT/IL2009/001066 patent/WO2010055510A2/en not_active Ceased
- 2009-11-12 JP JP2011535211A patent/JP2012508865A/ja active Pending
- 2009-11-12 AU AU2009315230A patent/AU2009315230A1/en not_active Abandoned
- 2009-11-12 CN CN200980154256.5A patent/CN102388307B/zh not_active Expired - Fee Related
- 2009-11-12 CA CA2743590A patent/CA2743590A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN109142755B (zh) | 一种诊断早期食管鳞状细胞癌的四种自身抗体联合检测试剂盒及应用 | |
| CN111172279B (zh) | 外周血甲基化基因及idh1联合检测诊断肺癌模型 | |
| JP2008532014A5 (enExample) | ||
| CN106226516B (zh) | 一种双曲线定标定量免疫层析检测方法 | |
| CN109661578A (zh) | 用于区分细菌和病毒感染的蛋白质特征 | |
| JP2009522578A5 (enExample) | ||
| JP2012502281A5 (enExample) | ||
| MX2014014275A (es) | Genes nano46 y metodos para predecir el resultado del cancer de mama. | |
| JP2011506917A5 (enExample) | ||
| EP3504553A1 (en) | System and method for analysis of biological data | |
| JP2014512511A (ja) | 肺がん試験 | |
| CN104422768A (zh) | 一种联合检测早期卵巢癌标志物的抗体芯片试剂盒 | |
| CN112481380B (zh) | 一种评估晚期膀胱癌抗肿瘤免疫治疗反应性和预后生存的标志物及其应用 | |
| CN101424661B (zh) | 一种活动性肺结核病的血清诊断模型的建立方法 | |
| JP2012531581A5 (enExample) | ||
| JP2016519767A5 (enExample) | ||
| CN108548923B (zh) | 肺小细胞癌早期特异性自身抗体panel诊断试剂盒 | |
| JP2006508326A5 (enExample) | ||
| CN109735619A (zh) | 与非小细胞肺癌预后相关的分子标志物及其应用 | |
| CN111579786B (zh) | 一种用于高危人群早期食管鳞癌筛查的试纸条 | |
| JP2015519043A5 (enExample) | ||
| CN112946276A (zh) | I期肺腺癌患者术后复发风险预测系统及其应用 | |
| CN108802400B (zh) | 一种检测复合物IgA1-α1MG的方法及无创检测肾组织损伤的试剂盒 | |
| Xu et al. | Zwitterionic mesoporous engineering aids peptide-dependent pattern profiling for identification of different liver diseases | |
| JP6250351B2 (ja) | 好酸球性気道炎症に関する情報の取得方法およびそのような情報を取得するためのマーカー |